Compliance tool

The Pharmacy Guild of Australia has developed a tool, called MedsIndex, to help improve compliance with chronic disease medications.

Reform road map

A new tool to help pharmacists prepare for the approaching PBS reforms has been launched.

Pharmacists to take part in complementary research

The National Prescribing Service is encouraging pharmacists to support it’s research of complementary medicines.

Nearly 2/3 of Aussies die from heart disease or cancer

Bureau of Statistics figures indictate that the leading underlying cause of death for all Australians is still ischaemic heart diseases, contributing to 18% of all male deaths and 17% of all female deaths registered in 2006.

More action on type 2 diabetes: NPS

The National Prescribing Service has advised health professionals to be more aggressive in their management of patients with type 2 diabetes.

Pharmacists to screen for lung problems

A pilot program in the Hunter Valley will involve pharmacists in the management of Australia’s fifth-biggest killer, chronic obstructive pulmonary disease.

Death from heart attack less likely

New research shows dying from a heart attack is less likely than it was 10 years ago, but the outlook for lung cancer is worse, particularly among women.

Drug-free strategies for sleepless

The National Prescribing Service has recommended that insomniacs try non-medicine strategies before using Stilnox.

Pharmacists back OTC pill push

The Australian Democrats have called for over-the-counter availability of the oral contraceptive pill.Debate over the downscheduling of the oral contraceptive pill.

TGA decides against re-classifying Stilnox

The TGA has decided against re-classifying the sleeping pill Stilnox as a controlled substance….but instead has issued a warning about potential serious side effects.

Trial result for new prolonged-release statin

New research published in the American Journal of Cardiology reports that 83% of patients who experienced muscle related side effects on previous statin therapy for high cholesterol were free of these symptoms after treatment with the prolonged release statin, Lescol XL 80mg.

Pharmacists well-disposed to opioid substitution treatment

Pharmacists appear to feel positively towards providing opioid substitution treatment.

Please ensure you have Flash Player installed, and Javascript enabled in your Web Browser.

You can get the latest version of Flash Player Here